Equillium

$7.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.27 (-3.44%) Today
$0.00 (0.00%) As of 12:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Equillium and other stocks, options, and ETFs commission-free!

About EQ

Equillium, Inc. Common Stock, also called Equillium, is a biotechnology company, which engages in the development of products for severe immuno-inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly on March 16, 2017 and is headquartered in La Jolla, CA. The listed name for EQ is Equillium, Inc. Common Stock.

CEO
Bruce D. Steel
Employees
16
Headquarters
La Jolla, California
Founded
2017
Market Cap
230.79M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
834.10K
High Today
$8.02
Low Today
$7.32
Open Price
$7.87
Volume
271.23K
52 Week High
$27.05
52 Week Low
$2.20

EQ Earnings

-$0.45
-$0.30
-$0.15
-$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 25, After Hours

You May Also Like

CLX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure